Yayla, MuhammedCetin, DamlaAdali, YasemenKilicle, Pinar AksuToktay, Erdem2025-01-272025-01-2720182008-38662008-3874https://doi.org/10.22038/ijbms.2018.30149.7268https://hdl.handle.net/20.500.12428/23996Objective(s): The aim of this study is to determine the therapeutic effects of pomegranate seed oil, which is a powerful antioxidant and anti-inflammatory agent, on ovarian-ischemia and reperfusion injury in rats. Materials and Methods: Fifty-six female albino Wistar rats were divided into 7 equal groups. Group 1; Sham Operation, Group 2; Ischemia, Group 3; Ischemia + Reperfusion, Group 4; Ischemia + Pomegranate 0,32 ml / kg (IP), Group 5; Ischemia + Pomegranate 0.64 ml / kg, Group 6; Ischemia + Pomegranate 0,32 ml / kg + reperfusion, Group 7; Ischemia + Pomegranate 0,64 ml / kg + reperfusion. Three hours after ischemia and 3 hours after reperfusion, the study was terminated. Results: While NADPH oxidase activity, MDA and TNF-alpha levels were significantly increased, SOD activity and GSH levels were reduced in ischemia and I/R groups. Low dose pomegranate seed oil application reduced significantly oxidative stress and NADPH oxidase activity in both ischemic and ischemic/reperfusion groups. At the same time, low-dose pomegranate seed oil extract reduced TNF-alpha levels and significantly increased antioxidant activity. Conclusion: PSO demonstrated an important therapeutic effect in the treatment of ovarian ischemia and reperfusion injury.eninfo:eu-repo/semantics/closedAccessIschemia/ReperfusionOxidative stressOvaryPomegranate seed oilPunicaceaeRatsArticle21121262126810.22038/ijbms.2018.30149.7268Q3WOS:0004479266000102-s2.0-8505564750230627370Q2